Drug Information

    


     















Pharmacokinetics



Primidone is readily absorbed from
the gastrointestinal tract and is reported to have a plasma half-life
ranging from 10 to 15 hours, which is shorter than those of its
principal metabolites phenylethylmalonamide and phenobarbitone, both of
which are active. It is excreted in urine as unchanged drug (40%) and
metabolites.

Primidone is widely distributed but is only partially bound to plasma
protein; it has been suggested that it exhibits variable binding of up
to about 20%. It crosses the placenta and is distributed into breast
milk.

Top

  

Indication
& Dosage




Oral

TONIC-CLONIC (GRAND MAL) AND PARTIAL ESPECIALLY PSYCHOMOTOR SEIZURES:
Start wiht 125mg daily in late evenings. Increase if necessary, by 125mg
every 3 days upto 500mg/day. Further increments of 250mg given upto1.5g
in adults Children: Upto 2yrs-250-500mg daily. 2-5 yrs-500-750mg daily.
6-9yrs-0.75-1.0g daily. 6-9yrs-0.75-1.0g daily. Maintenance doses for
adults and children may be given in 2 divided doses

ESSENTIAL TREMOR: 50mg daily increasing gradually upto 750mg daily.

Top

  

Action



Raise seizure thresholds. Partly metabolised to
phenobarbitone which also exerts anticonvulsant activity.

Top

  

Interaction

Primidone is
metabolised in the body in part to phenobarbitone and interactions
recorded for phenobarbitone  might potentially occur in patients
receiving primidone. In addition, enzyme-inducing drugs enhance this
metabolism and have the potential to produce elevated phenobarbitone
concentrations.

Top

  


Adverse Effect & Precautions






Serious toxicity is rarely seen. Hedache, sedation, drowsiness,
irritability, anaemia and impairment of higher intellectual functions
may occur.



Precaution: Respiratory
disease, hepatic and renal diseases. Simulataneous administration of
primidone with alcohol and CNS depressants should be avoided. Sodium
valproate may inhibit the metabolism of primidone with alcohol and CNS
depressnats should be avoided. Sodium valproate may inhibit the
metabolism of primidone. Abrupt withdrawal. Children.

Pregnancy: Use with caution.

Breast Feeding: Use with caution.

Man: May be given in reduced dose

Top

  

Brands
available in market












MYSOLINE

ICI
TAB 250mg 10 27.12



Top

 








         

    
Drug Information
    

     

Pharmacokinetics

Primidone is readily absorbed from the gastrointestinal tract and is reported to have a plasma half-life ranging from 10 to 15 hours, which is shorter than those of its principal metabolites phenylethylmalonamide and phenobarbitone, both of which are active. It is excreted in urine as unchanged drug (40%) and metabolites.
Primidone is widely distributed but is only partially bound to plasma protein; it has been suggested that it exhibits variable binding of up to about 20%. It crosses the placenta and is distributed into breast milk.

Top
  

Indication & Dosage

Oral
TONIC-CLONIC (GRAND MAL) AND PARTIAL ESPECIALLY PSYCHOMOTOR SEIZURES: Start wiht 125mg daily in late evenings. Increase if necessary, by 125mg every 3 days upto 500mg/day. Further increments of 250mg given upto1.5g in adults Children: Upto 2yrs-250-500mg daily. 2-5 yrs-500-750mg daily. 6-9yrs-0.75-1.0g daily. 6-9yrs-0.75-1.0g daily. Maintenance doses for adults and children may be given in 2 divided doses
ESSENTIAL TREMOR: 50mg daily increasing gradually upto 750mg daily.

Top
  

Action

Raise seizure thresholds. Partly metabolised to phenobarbitone which also exerts anticonvulsant activity.

Top
  

Interaction

Primidone is metabolised in the body in part to phenobarbitone and interactions recorded for phenobarbitone  might potentially occur in patients receiving primidone. In addition, enzyme-inducing drugs enhance this metabolism and have the potential to produce elevated phenobarbitone concentrations.

Top
  

Adverse Effect & Precautions

Serious toxicity is rarely seen. Hedache, sedation, drowsiness, irritability, anaemia and impairment of higher intellectual functions may occur.

Precaution: Respiratory disease, hepatic and renal diseases. Simulataneous administration of primidone with alcohol and CNS depressants should be avoided. Sodium valproate may inhibit the metabolism of primidone with alcohol and CNS depressnats should be avoided. Sodium valproate may inhibit the metabolism of primidone. Abrupt withdrawal. Children.
Pregnancy: Use with caution.
Breast Feeding: Use with caution.
Man: May be given in reduced dose

Top
  

MYSOLINE

ICI

TAB

250mg

10

27.12

Top
 

By |2022-07-20T16:44:58+00:00July 20, 2022|Uncategorized|Comments Off on Primidone

About the Author: